JAGLX - Janus Henderson Global Life Sciences T
Nasdaq - Nasdaq Delayed Price. Currency in USD
56.42
+0.82 (+1.47%)
At close: 8:00PM EST
Stock chart is not supported by your current browser
| Previous Close | 55.60 |
| YTD Return | 9.00% |
| Expense Ratio (net) | 0.91% |
| Category | Health |
| Last Cap Gain | 0.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Average |
| Sustainability Rating |
| Net Assets | 3.83B |
| Beta (3Y Monthly) | 1.07 |
| Yield | 0.00% |
| 5y Average Return | N/A |
| Holdings Turnover | 46.00% |
| Last Dividend | 0.00 |
| Average for Category | N/A |
| Inception Date | Dec 31, 1998 |
- Zacks•4 months ago
3 Healthcare Funds to Ride VC Funding Wave
U.S. healthcare has caught the fancy of American and foreign venture capitalists alike.
- Zacks•5 months ago
Play a Robust Biotech Industry With These 3 Solid Funds
A burgeoning economy and steady influx of funds make conditions ripe for diversification and further strengthening of the capital base.
We're sorry this is all we were able to find about this topic.
